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Numerous Gram-negative bacterial pathogens employ type III secretion systems (T3SSs)
to inject effector proteins into eukaryotic cells. The activation of the type III secretion
(T3S) process is tightly controlled in all T3SSs. In Yersinia pestis, the secretion of
effector proteins, termed Yersinia outer proteins (Yops), is regulated by the activity of
the YopN/SycN/YscB/TyeA complex. YopN is a secreted protein that interacts with the
SycN/YscB chaperone via an N-terminal chaperone-binding domain (CBD) and with TyeA
via a C-terminal TyeA-binding domain (TBD). Efficient YopN secretion is dependent upon
its N-terminal secretion signal (SS), CBD, and the SycN/YscB chaperone. In this study,
we investigate the role of the YopN CBD in the regulation of Yop secretion. Analysis of
YopE/YopN hybrid proteins in which the YopN SS or SS and CBD were replaced with the
analogous regions of YopE indicated that the YopN CBD or SycN/YscB chaperone play a
role in the regulation of Yop secretion that is independent of their established roles in YopN
secretion. To further analyze the role of the YopN CBD in the regulation of Yop secretion a
series of tetra-alanine substitution mutants were generated throughout the YopN CBD.
A number of these mutants exhibited a defect in the regulation of Yop secretion but
showed no defect in YopN secretion or in the interaction of YopN with the SycN/YscB
chaperone. Finally, conditions were established that enabled YopN and TyeA to regulate
Yop secretion in the absence of the SycN/YscB chaperone. Importantly, a number of the
YopN CBD mutants maintained their defect in the regulation of Yop secretion even under
the established SycN/YscB chaperone-independent conditions. These studies establish a
role for the CBD region of YopN in the regulation of Yop secretion that is independent from
its role in YopN secretion or in the binding of the SycN/YscB chaperone.
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INTRODUCTION
Numerous Gram-negative bacterial pathogens use type III secre-
tion systems (T3SSs) to inject effector proteins into eukaryotic
cells (Ghosh, 2004). The injected proteins function to disrupt host
signaling pathways in amanner that benefits the pathogen. T3SSs,
at a minimum, consist of a multicomponent secretion apparatus
(or injectisome) that spans the bacterial inner and outer mem-
branes, translocon proteins that assemble a pore-like structure
in the eukaryotic membrane, anti-host effector proteins, type
III secretion (T3S) chaperones, and a variety of regulatory pro-
teins that control the assembly of the secretion apparatus and the
selection of T3S substrates (Hueck, 1998).
All three human pathogenic yersiniae (Yersinia pestis, Y. pseu-
dotuberculosis, and Y. enterocolitica) carry a ca. 70 kb plasmid
encoding a T3SS that is required for virulence (Ben-Gurion and
Shafferman, 1981; Ferber and Brubaker, 1981; Cornelis et al.,
1998). These T3SSs function to inject at least five effector proteins,
termed Yersinia outer proteins (Yops) into targeted eukaryotic
cells (Trosky et al., 2008). The injected effector proteins act to
block bacterial phagocytosis or suppress the production of pro-
inflammatory cytokines. These activities allow the yersiniae to
survive and multiply in the extracellular milieu of their hosts.
Assembly of the T3S apparatus requires the participation of
at least 21 Yersinia secretion (Ysc) proteins [reviewed in Cornelis
and Van Gijsegem (2000)]. The assembled T3S apparatus ini-
tially secretes YscI and YscF that assemble an internal rod-like
structure and an extracellular needle-like structure, respectively
(Edqvist et al., 2003; Wood et al., 2008). The secreted YscP pro-
tein serves as a molecular ruler that directs a YscU-dependent
substrate specificity switch from needle-type substrates (YscF,
YscI, and YscP) to translocator- and/or effector-type substrates
when the needle reaches the proper length (Journet et al., 2003;
Agrain et al., 2005; Sorg et al., 2007; Wood et al., 2008). At
this point, a complex composed of the YopN, SycN, YscB, and
TyeA proteins is targeted to the injectisome and functions to
prevent Yop secretion until a secretion triggering signal is encoun-
tered (Day and Plano, 1998; Ferracci et al., 2005). Importantly,
the YopN/SycN/YscB/TyeA-dependent block in Yop secretion can
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only be established in environments that contain millimolar lev-
els of extracellular calcium (≥1mM) for instance the blood or
extracellular milieu of amammalian host. In vitro, Yop secretion is
triggered in the absence of calcium, whereas in vivo, Yop secretion
is initiated upon contact between a bacterium and a eukaryotic
cell (Rosqvist et al., 1994). Importantly, proteins homologous to
YopN and TyeA (YopN/MxiC/InvE family proteins) are present
in essentially all T3SSs and function to prevent effector protein
secretion prior to receiving a secretion activation signal (Pallen
et al., 2005). Contact with a host cell membrane serves as an
activation signal for many T3SSs; however, other T3SS-specific
activation signals have been identified including the dye Congo
Red (Bahrani et al., 1997) and alterations in pH (Yu et al., 2010).
YopN is a 293 residue secreted and translocated protein that
interacts with the heterodimeric SycN/YscB chaperone via an
N-terminal chaperone-binding domain (CBD; residues 32–76)
and with TyeA via a C-terminal TyeA-binding domain (TBD)
(Schubot et al., 2005). The SycN/YscB chaperone and TyeA
are both required for the calcium-dependent regulation of the
T3S process; however, while the SycN/YscB chaperone promotes
efficient YopN secretion and translocation, TyeA functions to
suppress YopN translocation (Cheng et al., 2001; Day et al.,
2003). TyeA is believed to mediate a binding event that physi-
cally arrests the YopN/TyeA complex at the T3S apparatus in a
position that blocks Yop secretion. Activation of the T3S pro-
cess triggers YopN secretion and removes the block in secretion.
Collectively, the YopN/SycN/YscB/TyeA complex is thought to
function as a molecular plug that functions to control the access
of T3S effectors and translocators to the T3S apparatus.
Proteins homologous to YopN and TyeA are present in essen-
tially all non-flagellar T3SSs; however, in many T3SSs domains
homologous to YopN and TyeA are present in a single pro-
tein (Pallen et al., 2005; Silva-Herzog et al., 2011). In contrast,
proteins homologous to SycN or YscB are present in only a
small subset of T3SSs. Interestingly, a large region of the YopN
CBD is conserved among all YopN/InvE/MxiC family proteins
regardless of the presence or absence of an identified cognate
chaperone (Pallen et al., 2005; Younis et al., 2010). This is
true even for the Salmonella enterica InvE protein, which is
not secreted and has no identified cognate chaperone (Kubori
and Galan, 2002). The CBDs of numerous effector proteins
have been shown to either contain, or overlap with, peptide
sequences implicated in diverse functions unrelated to the secre-
tion or translocation of the effector. For example, the CBD
of YpkA (YopO), YopE, and YopT each contain a membrane
localization domain that is masked within the bacterial cell by
the appropriate chaperone (Letzelter et al., 2006). Similarly, the
CBD of YopH binds SycH within the bacterial cell and tyrosine-
phosphorylated target proteins within the host cell (Montagna
et al., 2001). To begin to investigate the role of the YopN CBD
in YopN function, we used site-directed mutagenesis to identify
residues required for YopN secretion and/or the regulation of Yop
secretion.
MATERIALS ANDMETHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
Y. pestis and Escherichia coli strains used in this study are listed
in Table 1. All Y. pestis strains used in this study carry a deletion
of the pgm locus (pgm-) and thus, are avirulent via peripheral
routes of infection (Une and Brubaker, 1984). E. coli and Y. pestis
strains were routinely grown in heart infusion broth (HIB) or on
tryptose blood agar (TBA) plates (Difco Laboratories) at 37◦C or
27◦C, respectively. For growth and secretion assaysY. pestis strains
were grown in thoroughly modified Higuchi’s (TMH) medium
(Goguen et al., 1984) overnight at 27◦C, and diluted the next day
to an optical density at 620 nm (OD620) of 0.20 in 2ml of fresh
media with or without 2.5mM CaCl2 unless otherwise stated.
Cultures were grown for 1 h at 27◦C then shifted to 37◦C for
5 h of growth. One shot® TOP10 chemically competent E. coli
(Invitrogen Life Technologies) or E. coli DH5α were used for rou-
tine cloning experiments. Bacteria with resistance markers were
cultured in the presence of the appropriate antibiotic(s) at a final
Table 1 | Bacterial strains used in this study.
Strain Relevant characteristicsb Source
Y. pestisa
KIM8.P39 (parent) pCD1 (sycE-yopE::km), pPCP1− , pMT1 Torruellas et al., 2005
KIM8.P62 (yopE yopN) pCD1 (sycE-yopE::km yopN) pPCP1−, pMT1 Torruellas et al., 2005
KIM8-3001.P71 (yopNtyeA) pCD1 (sycE-yopE::km yopNtyeA) pPCP1− , pMT1 Ferracci et al., 2004
KIM8-3001.P1 (yscB) pCD1 (yscB) pPCP1− , pMT1 Jackson et al., 1998
KIM8-3001.PF1 (sycN yscB) pCD1 (sycE-yopE::km sycN yscB) pPCP1− , pMT1 Day and Plano, 1998
KIM8.PS2 (yopNtyeAsycN yscB) SmrpCD1 (sycE-yopE::dhfr yopN tyeAsycN yscB) pPCP1−, pMT1 This study
E. coli
DH5α F-80 d lacZ M15, (lacZYA argF )U189, endA1 recA1 hsdR17 deoR supE44
thi-1 gyrA96 relA1
Cambau et al., 1993
Top10 F-mcrA (mrr-hsdRMS-mcrBC) ϕ80lacZM15 lacX74 nupG recA1 araD139
(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ−
Invitrogen Life Technologies
aAll Y. pestis strains are avirulent due to a deletion of the pgm locus (Une and Brubaker, 1984).
bPlasmids native to Y. pestis include pCD1 (Perry et al., 1998), pPCP1 (Sodeinde et al., 1988) that encodes the outer membrane plasminogen activator protease (Pla)
that has been demonstrated to degrade secreted Yops and pMT1 encoding the capsular protein (Protsenko et al., 1983).
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concentration of 25μg/ml (chloramphenicol and kanamycin) or
50μg/ml (ampicillin and streptomycin).
CONSTRUCTION OF PLASMIDS ENCODING YopE-YopN HYBRID
PROTEINS
Plasmids pYopE1−15-YopN16−293-GSK and pYopE1−85-
YopN86−293-GSK were constructed via the PCR-ligation-PCR
technique (Ali and Steinkasserer, 1995). DNA fragments encod-
ing sycE and yopE amino-acid residues 1–15 as well as sycE and
yopE residues 1–85 were amplified from plasmid pCD1 using
upstream primer SycE-F and downstream primers YopE-15R
or YopE-85R, respectively (oligonucleotides used in this study
are listed in Table 2). The yopN sequences encoding amino-acid
residues 16-293-GSK and 86-293-GSK were amplified from
plasmid pBAD30-YopN-GSK using upstream primers YopN-16F
or YopN-86F, respectively and downstream primer YopN-GSK-R.
The four resulting PCR fragments were purified, phosphorylated
using T4 polynucleotide kinase and ligated to the appropriate
DNA fragment with T4 DNA ligase. The ligated products were
used as template for a second PCR reaction using the outside
primers SycE-F and YopN-GSK-R carrying KpnI and XbaI
restriction endonuclease sites, respectively. These fragments
were inserted into KpnI- and XbaI-digested pBAD18 (Guzman
et al., 1995) generating plasmids pYopE1−15-YopN16−293-GSK
and pYopE1−85-YopN86−293-GSK. Plasmid pBAD18-YopN-GSK
was constructed by excising a YopN-GSK-encoding EcoRI-XbaI
fragment from plasmid pBAD30-YopN-GSK (Garcia et al.,
2006) and inserting this fragment into EcoRI- and XbaI-digested
pBAD18.
GENERATION OF PLASMIDS ENCODING YopN CBD TETRA-ALANINE
SUBSTITUTIONMUTANTS
Plasmid pBAD30-YopN-GSK encodes a full length fully func-
tional YopN protein with a C-terminal GSK tag (Garcia et al.,
2006). Tetra-alanine scanning mutagenesis of yopN from
pBAD30-YopN-GSK was performed via oligonucleotide-directed
mutagenesis in combination with Gateway cloning technology
(Invitrogen Life Technologies). Mutation of four consecutive
codons encoding YopN CBD residues to codons encoding four
alanine residues were generated using the PCR-ligation-PCR
technique (Ali and Steinkasserer, 1995) using outside primers
YopN-KpnI-F and downstream primer YopN-GSK-R. Inside
primers were created to generate four alanine substitutions
at the desired positions of the yopN sequence. For example
to generate YopN(G32-R35A); primers YopN-KpnI-F and
YopN-A33R were used to create an initial DNA fragment
(fragment A). Primers YopN-A34F and YopN-GSK-R were
used to generate a second DNA fragment (fragment B). The
resultant DNA fragments (A and B) were purified from agarose
gels, phosphorylated using T4 polynucleotide kinase, and
ligated using T4 DNA ligase. A final PCR product was gen-
erated using the ligation reaction as template with outside
primers YopN-KpnI-F and YopN-GSK-R. The final PCR prod-
uct was inserted into the pCR8/GW/TOPO vector using the
pCR8/GW/TOPO TA cloning kit (Invitrogen) and the insert
sequence confirmed via DNA sequencing. The correct DNA
fragment was inserted into a gateway compatible pBAD30
Table 2 | Oligonucleotides used in this study.
Name Sequencea
SycE-F 5′-TTTGGTACCTCAACTAAATGACCGTGGTGGTGA-3′
YopE-15R 5′-TGTCGGCAGGGGCAGTGATGTAGA-3′
YopE-85R 5′-CGGTTTATGGCTCCCTCCGAGAACAT-3′
YopN-16F 5′-AATGAGCGTCCAGAGATTGCCAGTAGT-3′
YopN-86F 5′-CAGGTTAATCAATACCTTAGCAAAGTT-3′
YopN-GSK-R 5′-TTTTCTAGAGAGTCAACTTTCAGCGAAACTAGTAG
TGCG-3′
YopN-KpnI-F 5′-TTTGGTACCGAAAAATAGCCAAGC-3′
YopN-NheI 5′-TTTGCTAGCTAAACTGTTCATCTCAGGGAGTAG-3′
TyeA-KpnI 5′-TTTGGTACCGGTTCAATCCAACTCACTCAATTC-3′
YopN-85R 5′-GAGCCTGGCTGTCACTTAATT-3′
YopN-SycN-P1 5′-CCCGCTGCATAATGAGCGTCCAGAGATTGCCAGTA
GTCATGTGTAGGCTGGAGCTGCTTC-3′
YopN-SycN-P2 5′-CTGACTTTCCCCTAACCACCCGCTCGCAGCGGTAA
AGCCATTGAATATCCTCCTTAGT-3′
YopN-A33-R 5′-GGCCGCCCAGAGTCTGATTTACGATCTG-3′
YopN-A34-F 5′-GCTGCAGGAGAATCTGTGCAGATAGTC-3′
YopN-A37-R 5′-GGCCGCCCGAAATTGACCCAGAGTCTG-3′
YopN-A38-F 5′-GCTGCGCAGATAGTCAGCGGCACTCTG-3′
YopN-A41-R 5′-GGCCGCCACAGATTCTCCCCGAAATTG-3′
YopN-A42-F 5′-GCCGCCGGCACTCTGCAGTCTATAGCT-3′
YopN-A45-R 5′-GGCCGCGCTGACTATCTGCACAGATTC-3′
YopN-A46-F 5′-GCGGCGTCTATAGCTGATATGGCAGAA-3′
YopN-A49-R 5′-GGCCGCCTGCAGAGTGCCGCTGACTAT-3′
YopN-A50-F 5′-GCTGCTATGGCAGAAGAGGTAACATTT-3′
YopN-A53-R 5′-GGCCGCATCAGCTATAGACTGCAGAGT-3′
YopN-A54-F 5′-GCAGCGGTAACATTTGTCTTCTCCGAGA-3′
YopN-A57-R 5′-GGCCGCCTCTTCTGCCATATCAGCTAT-3′
YopN-A58-F 5′-GCTGCCTTCTCCGAGCGTAAGGAGCTC-3′
YopN-A61-R 5′-GGCCGCGACAAATGTTACCTCTTCTGC-3′
YopN-A62-F 5′-GCGGCTAAGGAGCTCTCCCTCGACAAA-3′
YopN-A65-R 5′-GGCCGCACGCTCGGAGAAGACAAATGT-3′
YopN-A66-F 5′-GCCGCCCTCGACAAACGCAAATTAAGT-3′
YopN-A69-R 5′-GGCCGCGGAGAGCTCCTTACGCTCGGA-3′
YopN-A70-F 5′-GCAGCCAAATTAAGTGACAGCCAGGCT-3′
YopN-A73-R 5′-GGCCGCGCGTTTGTCGAGGGAGAGCTC-3′
YopN-A74-F 5′-GCTGCCAGCCAGGCTCGAGTTAGCGAC-3′
aRestriction enzyme recognition sites are underlined.
vector using Gateway LR Clonase II mix (Invitrogen). This
procedure was repeated to generate plasmids pBAD30-YopN
(G36-V39A)-GSK, pBAD30-YopN(Q40-S43)-GSK, pBAD
30-YopN(G44-Q47A)-GSK, pBAD30-YopN(S48-D51A)-GSK,
pBAD30-YopN(M52-E55A)-GSK, pBAD30-YopN(V56-V59A)-
GSK, pBAD30-YopN(F60-R63A)-GSK, pBAD30-YopN(K64-S
67A)-GSK, pBAD30-YopN(L68-R71A)-GSK, and pBAD30-
YopN(K72-D75A)-GSK encoding each of the YopN CBD
tetra-alanine substitution mutants.
GENERATION OF pBAD18-YopN/TyeA PLASMIDS
Plasmid pBAD18-YopN/TyeA encodes full length YopN and TyeA
under the control of the PBAD promoter of plasmid pBAD18-Cm
(Guzman et al., 1995). A DNA fragment encoding YopN andTyeA
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was amplified from plasmid pCD1 using primers YopN-NheI and
downstream primer TyeA-KpnI harboring NheI and KpnI sites,
respectively. The DNA fragment was digested with NheI and
KpnI and ligated to NheI- and KpnI-digested pBAD18-Cm. The
vector carrying the correct DNA insert was confirmed by DNA
sequence analysis (Genewiz). Plasmids pBAD18-YopN(S48-D51
A)/TyeA, pBAD18-YopN(M52-E55A)/TyeA, pBAD18-YopN(V5
6-V59A)/TyeA, pBAD18-YopN(F60-R63A)/TyeA, pBAD18-
YopN(K64-S67A)/TyeA, pBAD18-YopN(L68-R71A)/TyeA, and
pBAD18-YopN(K72-D75A)/TyeA were generated using the
PCR-ligation-PCR technique. DNA fragments encoding the
respective YopN CBD tetra-alanine substitutions were amplified
from plasmids pBAD30-YopN(S48-D51A)-GSK, pBAD30-Yo
pN(M52-E55A)-GSK, pBAD30-YopN(V56-V59A)-GSK, pB
AD30-YopN(F60-R63A)-GSK, pBAD30-YopN(K64-S67A)-GSK,
pBAD30-YopN(L68-R71A)-GSK, and pBAD30-YopN(K72-
D75A)-GSK using primers YopN-NheI and YopN-85R. A second
fragment was amplified from plasmid pBAD18-YopN/TyeA using
primers YopN-86-F and TyeA-KpnI. The two fragments were
agarose gel purified, phosphorylated, and ligated to each other.
The resultant DNA fragments were digested with NheI and KpnI
restriction endonucleases and ligated to NheI- and KpnI-digested
pBAD18-Cm, generating plasmids pBAD18-YopN(S48-D5
1A)/TyeA, pBAD18-YopN(M52-E55A)/TyeA, pBAD18-YopN(V5
6-V59A)/TyeA, pBAD18-YopN(F60-R63A)/TyeA, pBAD18-
YopN(K64-S67A)/TyeA, pBAD18-YopN(L68-R71A)/TyeA, and
pBAD18-YopN(K72-D75A)/TyeA.
CONSTRUCTION OF A Y. pestis yopNtyeAsycN yscB DELETION STRAIN
Deletion of the yopN, tyeA, and sycN genes from a Y. pestis
yscB deletion strain (KIM8-3001.PF1) (Jackson et al., 1998) and
insertion of a kan gene was accomplished using lambda Red-
mediated recombination essentially as described by Datsenko and
Wanner (2000). The PCR product used to construct the gene
replacement was amplified from plasmid pKD4 using primers
YopN-SycN-P1 and YopN-SycN-P2. The PCR product was gel
purified, ethanol precipitated, and resuspended in 10μl of dH2O.
Plasmid pKD46 encoding the Red recombinase was electropo-
rated into the yscB deletion strain and grown in HIB for 2 h with
0.2% L-arabinose. Electrocomptent cells were prepared as pre-
viously described (Jackson et al., 2004) and electroporated with
the purified PCR product. Gene replacements were confirmed
by PCR analysis. Plasmid pCP20 (Cherepanov and Wackernagel,
1995) that encodes the FLP recombinase was electroporated into
the kanamycin resistant strain to remove the FLP recognition
target-flanked kan cassette. Plasmid pKD46 and pPCP20 were
cured from the Y. pestis yopNtyeAsycN yscB deletion mutant
(KIM8-3001.PS2) by overnight growth at 39◦C.
CROSS-LINKING AND IMMUNOPRECIPITATION OF YopN, SycN, YscB,
AND TyeA
The yopN yopE Y. pestis strains transformed with
pBAD30-YopN-GSK or the pBAD30-YopN-GSK derivatives
encoding the YopN CBD tetra-alanine substitution mutants
were grown in the absence of calcium at 37◦C for 3 h. The
immunoprecipitation procedure was adapted from the method
of Day and Plano (1998). Bacterial cells from 20ml cultures were
harvested at an OD620 = 1.2, resuspended in 3ml of 20mM
Hepes, 250mM NaCl, pH 7.4, and lysed by passage through a
French pressure cell. Triton X-100 (0.5% final concentration)
and SDS (0.1% final concentration) were added to the lysates and
the solubilized lysates were centrifuged at 10,000 × g for 10min
at 4◦C. Soluble fractions from the strains were cross-linked with
the thio-cleavable amine-reactive cross-linker DSP (Thermo
Scientific) for 20min at room temperature at a final concentra-
tion of 1mM. Samples were immunoprecipitated overnight with
20μl polyclonal antiserum specific for YopN. Antigen-antibody
complexes were collected by the addition of 80μl of 40% (w/v)
EZview Red Protein A Affinity Gel (Sigma) that was resuspended
in immunoprecipitation buffer (20mM Hepes, 250mM NaCl,
0.5% Triton X-100, 0.1% SDS, pH 7.4) and rotated at 4◦C for 2 h.
Protein-A Sepharose antigen-antibody complexes were collected
by centrifugation at 8200 × g for 30 s at room temperature. The
samples were washed three times with 1ml of immunoprecipita-
tion buffer, eluted with 100μl electrophoresis buffer containing
5% βME (cleaves the DSP cross-links), boiled for 3min and
analyzed by SDS-PAGE and immunoblotting.
SDS-PAGE AND IMMUNOBLOTTING
Volumes of cellular fractions corresponding to equal numbers
of bacteria were mixed 1:1 (v/v) with 2X electrophoresis sample
buffer and analyzed by SDS-PAGE and immunoblot analysis as
described previously (Ferracci et al., 2005) with rabbit polyclonal
antisera specific for YopE, YopM, YopN, SycN, YscB, TyeA, or
YscW (Plano and Straley, 1995; Day and Plano, 1998). Proteins
were visualized using an alkaline phosphatase-conjugated sec-
ondary antibody (Sigma) and 1-Step NBT/BCIP Development
Solution (Thermo Scientific) according to the Manufacturer’s
directions.
RESULTS
ROLE OF THE YopN CBD IN THE REGULATION OF Yop SECRETION
YopN secretion is dependent on an N-terminal secretion signal
(SS; residues 2–15), a CBD (residues 32–76), and the SycN/YscB
chaperone (Day and Plano, 1998; Goss et al., 2004). To begin to
investigate the role of the YopN SS and CBD in the regulation
of Yop secretion, we replaced the YopN SS or SS and CBD with
the analogous regions of YopE (Woestyn et al., 1996; Lloyd et al.,
2001) to determine if the YopN N-terminus or SycN/YscB chap-
erone has a unique role in the regulation of Yop secretion. YopE
is a secreted effector protein with no direct role in the calcium-
dependent regulation of the T3S process. Constructs encoding
YopN-GSK (pBAD18-YopN-GSK), YopE1−15-YopN16−293-GSK,
and YopE1−85-YopN86−293-GSK were generated and moved into
ayopE yopN Y. pestis strain. Sequences encoding a C-terminal
GSK-epitope tag (Garcia et al., 2006), which does not affect YopN
secretion or function, were included in each of the constructs. In
addition, sequences encoding the YopE-specific chaperone SycE
(Wattiau and Cornelis, 1993) were included in the constructs
encoding the two YopE-YopN hybrid proteins. To determine if
the hybrid proteins were expressed, secreted, and functional,
the strains were grown at 37◦C in the presence and absence
of 2.5mM calcium and bacterial pellet and culture supernatant
fractions were analyzed by SDS-PAGE and immunoblotting with
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antibodies specific for YopN and YopM (Figure 1). The parent
strain (KIM8.P39) and the yopE yopN strain complemented
with plasmids encoding YopN-GSK or YopE1−15-YopN16−293-
GSK secreted YopM and YopN in the absence but not in the
presence of calcium, confirming that the YopN SS has no unique
role in the regulation of secretion and can be functionally replaced
with the YopE SS. In contrast, the strain expressing YopE1−85-
YopN86−293-GSK secreted YopM and YopN in both the presence
and absence of calcium, indicating that the YopN CBD has a
role in the regulation of Yop secretion that cannot be comple-
mented by the YopE CBD and SycE chaperone. Importantly,
both YopE-YopN hybrid proteins were highly expressed and effi-
ciently secreted in the absence of calcium, suggesting that the
defect in the regulation of secretion was not due to a defect in
secretion per se.
SITE-DIRECTEDMUTAGENESIS OF THE YopN CBD
To further investigate the role of the YopN CBD in the regulation
of Yop secretion, a series of tetra-alanine substitution mutants
(XXXX → AAAA) were constructed throughout the sequence
encoding the CBD (residues 32–76) of plasmid pBAD30-YopN-
GSK (Garcia et al., 2006). In total, 11 tetra-alanine substitution
mutants were generated, transformed into Y. pestis KIM8.P62
(yopE yopN) and assessed by growth and secretion assays
(Figure 2). All of the CBD tetra-alanine substitution mutants
were stably expressed and efficiently secreted in the absence of
calcium (Figure 2B). YopN CBDmutants G32-R35A, G36-V39A,
Q40-S43A, and G44-Q47A showed normal calcium-regulated
FIGURE 1 | The YopN CBD but not the N-terminal secretion signal is
required to regulate Yop secretion. Immunoblot analysis of culture
supernatant (S) and cell pellet (P) fractions of Y. pestis KIM8.P39 (parent),
KIM8.P62 (yopN yopE), and KIM8.P62 expressing YopN-GSK,
YopE1−15-YopN16−293-GSK or YopE1−85-YopN86−293-GSK grown in the
presence (+) or absence (−) of 2.5mM calcium for 5 h at 37◦C. Antisera
specific for YopN or YopM were used to detect the expression and
secretion of the respective proteins. The dashed line indicates the margins
of two blots shown in a merged image.
secretion of YopM (Figure 2A). These mutants specifically altered
the CBD region that directly interacts with SycN (Schubot et al.,
2005) (Figure 3). In contrast, all of the tetra-alanine substitu-
tion mutants, except the YopN(K64-S67A) mutant, that spanned
YopN CBD residues 48–75, the CBD region that interacts with
YscB (Schubot et al., 2005), secreted YopM in both the presence
and absence of calcium, demonstrating that this region of the
CBD is required for the regulation of Yop secretion (Figure 2B).
The YopN(K64-S67A) mutant exhibited an intermediate pheno-
type and secreted only low levels of YopM in the presence of cal-
cium. As expected, the YopN CBDmutants that secreted YopM in
the presence of calcium also secreted YopN in the presence of cal-
cium (data not shown). Interestingly, the region of the CBD that
interacts with SycN is not conserved among YopN/InvE/MxiC
family members; in contrast, the CBD region that interacts with
YscB and that is essential for the regulation of secretion is well-
conserved among YopN/InvE/MxiC family members regardless if
they express a YopN-specific chaperone (Pallen et al., 2005) sug-
gesting that this region may have a conserved function in the
regulation of the T3S process.
INTERACTION OF THE SycN/YscB CHAPERONEWITH YopN CBD
MUTANTS
The SycN/YscB chaperone is required for efficient YopN secretion
and for the regulation of Yop secretion (Day and Plano, 1998);
thus, CBD mutants defective in the regulation of Yop secretion
may alter the interaction between YopN and the SycN/YscB chap-
erone. The interaction of the various YopN CBD tetra-alanine
substitution mutants with SycN, YscB, and TyeA was investigated
using dithiobis-succinimidyl propionate (DSP) cross-linking and
immunoprecipitation (Figure 4). Antisera specific for YopN pre-
cipitated YopN from all of the strains expressing either YopN or
a YopN CBD mutant. As expected, TyeA, but not the lipoprotein
chaperone YscW, co-precipitated with all the YopNCBDmutants;
although YopN(K64-S67A) appeared to bind reduced levels of
TyeA compared to the other YopN proteins. The SycN/YscB chap-
erone also efficiently co-precipitated with the YopNCBDmutants
with the exception of YopN(G44-Q47A) and YopN(S48-D51A).
The SycN/YscB chaperone only binds to YopN as a heterodimer
(Day and Plano, 1998); thus, the low amounts of co-precipitating
YscB, but normal amounts of SycN, associated with YopN(L68-
R71A) and YopN(K72-D75A) are likely due to the loss of critical
lysine residues (K70A or K72A) required for DSP-dependent
cross-linking of these mutant YopN proteins with YscB. These
studies indicate that the YopN CBD mutants defective in the reg-
ulation of Yop secretion, with the exception of YopN(G44-Q47A)
and YopN(S48-D51A), still bind the SycN/YscB chaperone; how-
ever, it is possible that a subset of these mutants exhibit sub-
tle, but possibly significant, alterations in SycN/YscB chaperone
binding that cannot be differentiated via DSP cross-linking and
immunoprecipitation.
ROLE OF THE SycN/YscB CHAPERONE IN THE REGULATION OF Yop
SECRETION
Previous studies conducted using sycN and/or yscB deletion
strains have demonstrated that the SycN/YscB chaperone is
required for efficient YopN secretion, YopN translocation, and
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FIGURE 2 | Residues within the YopN CBD are required to regulate Yop
secretion. A series of tetra-alanine substitution mutants were constructed
within YopN CBD residues 32–75. (A) Expression and secretion of YopM
by Y. pestis strains expressing YopN CBD tetra-alanine mutants. KIM8.P39
(yopE parent), KIM8.P62 (yopN yopE), and KIM8.P62 transformed
with either pBAD30-YopN-GSK or one of eleven pBAD30-YopN-GSK
derivatives encoding YopN CBD tetra-alanine substitution mutants were
grown for 5 h at 37◦C in the presence (+) and absence (−) of 2.5mM
calcium. Culture supernatant (S) and cell pellet (P) fractions were analyzed
by SDS-PAGE and immunoblot analysis with antiserum specific for YopM.
(B) Expression (P) and secretion (S) of YopN and the YopN tetra-alanine
substitution mutants by Y. pestis strains grown at 37◦C in the absence of
calcium. YopN was detected via immunoblot analysis with antiserum
specific for YopN.
for the regulation of Yop secretion (Day and Plano, 1998; Cheng
et al., 2001; Day et al., 2003). The SycN/YscB chaperone is
unique among class I T3S chaperones in that it functions as
a heterodimer, and thus, it is not unreasonable that it could
have a unique and direct role in the regulation of Yop secre-
tion. Conversely, SycN/YscB may simply function to promote
Yop secretion, a process that may need to be efficient to regulate
Yop secretion. To further investigate the role of the SycN/YscB
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FIGURE 3 | Mapping of YopN CBD residues involved in the regulation
of Yop secretion. (A) Diagram of YopN showing the location of the
secretion signal (SS), chaperone-binding domain (CBD), and TyeA-binding
domain (TBD). The extended arrow identifies additional residues contacted
by TyeA. Boxes above YopN each represent four YopN residues substituted
with four alanines in each YopN tetra-alanine mutant analyzed: open
boxes = wild-type calcium-dependent Yop secretion; filled boxes =
constitutive Yop secretion. (B) Ribbon model of the ternary complex of
YopN and the SycN/YscB chaperone. SycN, YscB, and YopN are
represented in magenta, brown, and blue, respectively. The side chains of
residues of YopN that resulted in constitutive Yop secretion when
substituted to alanine are shown in red. The broken line represents the
disordered region in the CBD (Schubot et al., 2005). This Figure was
generated by PYMOL (http://www.pymol.org).
chaperone in the regulation of Yop secretion, we examined the
role of SycN/YscB in the presence of increasing amounts of
extracellular calcium and upon overexpression of YopN and
TyeA (Figure 5). Y. pestis strains lacking sycN and yscB, yopN,
and tyeA or yopN, tyeA, sycN, and yscB secreted YopM in
the presence and absence of calcium (Figure 5A). Furthermore,
increasing the amount of extracellular calcium did not block
or significantly reduce the amount of YopM secreted by these
strains. Providing plasmid pBAD18-YopN/TyeA restored normal
calcium-dependent regulation of YopM secretion to the yopN
tyeA deletion strain and, unexpectedly, also to the yopNtyeAsycN
yscB deletion strain, demonstrating for the first time that calcium-
dependent regulation of Yop secretion can be achieved in the
absence of the SycN/YscB chaperone. Importantly, the increased
expression of YopN from plasmid pBAD18-YopN/TyeA resulted
in levels of YopN secretion that exceeded levels secreted by
the wild-type parent strain (Figure 5B) even in the absence of
the SycN/YscB chaperone. Overall, these results indicate that the
defect in the regulation of secretion associated with deletion
of sycN or yscB is due to the inefficient secretion of YopN in
the absence of its chaperone, a defect that can be overcome by
overexpression of YopN and TyeA.
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FIGURE 4 | Interaction of the SycN/YscB chaperone and TyeA
with YopN and the YopN tetra-alanine substitution mutants.
The interaction of YopN with the SycN/YscB chaperone was analyzed via
immunoprecipitation of YopN and co-immunoprecipitation of SycN and
YscB. Soluble lysates of Y. pestis KIM8.P39 (parent), KIM8.P62 (yopN
yopE), and KIM8.P62 expressing YopN-GSK or one of the 11 YopN-GSK
tetra-alanine substitution mutants grown at 37◦C in the absence of calcium
were cross-linked with DSP (1mM), a thio-cleavable amine-specific
cross-linking reagent. Antiserum specific for YopN was used to
immunoprecipitate YopN, each YopN CBD tetra-alanine mutant and
cross-linked SycN/YscB and/or TyeA. Precipitated and co-precipitated
proteins were boiled for 5min in sample buffer containing 5%
β-mercaptoethanol to break chemical cross-links and the resulting samples
were analyzed by SDS-PAGE and immunoblot analysis with anti-sera
specific for YopN, SycN, YscB TyeA, or YscW (control). The dashed lines
indicate the margins of individual blots shown in the merged images.
The establishment of conditions (overexpression of YopN
and TyeA) that enable SycN/YscB-independent regulation of Yop
secretion provides an additional means to differentiate whether
the constitutive secreting YopN CBD mutants are defective in
the regulation of secretion due a chaperone-dependent defect in
YopN secretion or to a defect in a novel chaperone-independent
function of this region of YopN. Each of the CBD mutants
that displayed a defect or partial defect in the regulation of
Yop secretion were moved into plasmid pBAD18-YopN/TyeA
and transformed into the yopNtyeAsycN yscB deletion mutant.
The YopN(M52-E55A), YopN(V56-V59A), and YopN(K72-D75)
tetra-alanine substitution mutants clearly maintained their
constitutive secretion phenotype under conditions where the
SycN/YscB chaperone is not required for YopN secretion or the
regulation of Yop secretion (Figure 6A). Importantly, each of
the YopN mutants was stably expressed and efficiently secreted
both in the presence and absence of the SycN/YscB chaperone
(Figure 6B). Levels of the YopN(K72-D75) mutant in the cell pel-
let were lower than the other mutants, suggesting that inefficient
expression of this particular mutant could have contributed to
the constitutive secretion of YopM in Figure 6A. Overall, these
results indicate that the constitutive secretion phenotype associ-
ated with the YopN(M52-E55A), YopN(V56-V59A), and possibly
the YopN(K72-D75) CBD mutants was not due to a defect in
the chaperone-dependent targeting of YopN for secretion, but
to a defect in a chaperone-independent function of the CBD
region of YopN in the calcium-dependent regulation of Yop
secretion.
DISCUSSION
Previous studies have established that the YopN SS, CBD, and
SycN/YscB chaperone are required for efficient YopN secretion
and translocation (Day and Plano, 1998; Goss et al., 2004; Garcia
et al., 2006). In this study, we examined the role of the YopN
SS, CBD, and SycN/YscB chaperone in the calcium-dependent
regulation of Yop secretion. The YopN SS could be functionally
replaced by the analogous region of YopE, indicating that the
YopN SS has no unique role in the regulation of Yop secretion. In
contrast, the function of the YopN CBD and SycN/YscB chaper-
one in the regulation of Yop secretion could not be restored by the
YopE CBD and SycE chaperone, suggesting that the YopN CBD
or the SycN/YscB chaperone has a direct role in the regulation of
Yop secretion. Importantly, the hybrid YopE/YopN proteins were
efficiently secreted, indicating that the YopN CBD or SycN/YscB
chaperone have a role in the regulation of Yop secretion that is
separate from their role in targeting YopN for secretion.
The role of T3S chaperones in the secretion process is not
fully understood and can vary depending upon the chaper-
one/substrate pair (Feldman and Cornelis, 2003). The chaperones
for YopN, and closely related homologs that interact with other
YopN/InvE/MxiC family proteins, are considered unique as they
function as heterodimers (Day and Plano, 1998), suggesting that
these chaperone complexes may have a distinctive role in the reg-
ulation of Yop secretion. Indeed, Y. pestis mutants lacking either
SycN or YscB secrete Yops constitutively, confirming a role for
these chaperones in the regulation of Yop secretion (Day and
Plano, 1998; Jackson et al., 1998). The SycN/YscB chaperone
Frontiers in Cellular and Infection Microbiology www.frontiersin.org January 2013 | Volume 3 | Article 1 | 8
Joseph and Plano YopN chaperone-binding domain
FIGURE 5 | Overexpression of YopN and TyeA results in increased
secretion of YopN and negates the requirement of the SycN/YscB
chaperone in the calcium-dependent regulation of Yop secretion.
(A) Secretion of YopM by Y. pestis KIM8-3001.P39 (parent), KIM8-3001.PF1
(sycN yscB), KIM8-3001.P71 (yopN tyeA), or KIM8.PS2 (yopN
sycN yscB tyeA) with or without plasmid pBAD18-YopN/TyeA. Y. pestis
strains were grown for 5 h in the presence of 0mM, 1.25mM, 2.5mM,
5mM, or 7.5mM calcium. Expression of YopN and TyeA from plasmid
pBAD18-YopN/TyeAwas induced with 0.2% L-arabinose. Secreted YopM was
detected by immunoblot analysis with antiserum specific for YopM.
(B) Expression and secretion of endogenous YopN by Y. pestis KIM8-3001.P39
(parent) and KIM8-3001.PF1 (sycN yscB) or plasmid-expressed YopN by
Y. pestis KIM8-3001.P71 (yopN tyeA) or KIM8-3001.PS2 (yopN sycN
yscB tyeA) carrying plasmid pBAD18-YopN/TyeA. Strains with or without
plasmid pBAD18-YopN/TyeAwere induced with 0.2% L-arabinose and grown
for 5 h in the absence of calcium. Bacterial pellet (P) and culture supernatant
(S) proteins were separated by SDS-PAGE and subjected to immunoblot
analysis with antisera specific for YopN.
could simply be required to efficiently target YopN to the T3S
apparatus; alternatively, SycN, YscB, or both proteins may have
a unique and direct role in the regulation of secretion, apart
from their role in YopN secretion. Interestingly, the yscB gene
and genes encoding yscB homologs in other T3SSs are located
within a multicistronic operon encoding components of the T3S
apparatus (yscBCDEFGHIJKL operon in the yersiniae) located ca.
9-kb from the yopN locus (Perry et al., 1998). Conversely, the
gene for sycN is encoded directly adjacent to the genes encod-
ing YopN and TyeA (as are the genes encoding sycN homologs
in other T3SSs), leading to speculation that YscB may mediate
a regulation-specific interaction with the T3S apparatus. Here
we present evidence that the SycN/YscB chaperone functions,
like most other class I T3S chaperones, to efficiently target the
YopN/TyeA complex to the T3S apparatus. Overexpression of
YopN and TyeA in a strain lacking both the SycN and YscB
chaperones restored normal calcium-dependent regulation of
Yop secretion, indicating that the SycN/YscB chaperone has no
unique and/or indispensable role in the calcium-dependent reg-
ulation of Yop secretion. Importantly, other independent lines
of evidence also support this contention. First, analysis of the
YopN32−277/SycN/YscB structure revealed that the SycN/YscB
chaperone, although unique, shows a high degree of structural
similarity to the homodimeric T3S chaperones, such as SycE
(Schubot et al., 2005). Furthermore, YopN/TyeA homologs in
other T3SSs, such as MxiC (Botteaux et al., 2009) and InvE
(Kubori and Galan, 2002) function in the absence of identified
SycN or YscB homologs, indicating again, that the proper regula-
tion of effector protein secretion can occur in the absence of SycN
or YscB-type chaperones.
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FIGURE 6 | Secretion of YopM by the YopN CBD tetra-alanine mutants
under SycN/YscB chaperone-independent conditions. (A) Y. pestis
KIM8-3001.PS2 (yopN sycN yscB tyeA) carrying pBAD18-YopN/TyeA or
pBAD18-YopN/TyeA derivatives encoding one of the YopN CBD tetra-alanine
mutants that previously exhibited a defect in the regulation of Yop secretion
under normal SycN/YscB chaperone-dependent conditions were grown for
5 h in the presence of 0mM, 1.25mM, 2.5mM, 5mM, or 7.5mM calcium.
Expression of YopN, the YopN CBD tetra-alanine substitution mutants and
TyeA from plasmid pBAD18-YopN/TyeA or derivatives of this plasmid was
induced with 0.2% L-arabinose. (A) Secreted YopM was detected by
immunoblot analysis with antiserum specific for YopM. (B) Expression and
secretion of YopN and YopN CBD tetra-alanine substitution mutants by Y.
pestis KIM8-3001.P71 (yopN tyeA) (+SycN/YscB) and KIM8.PS2 (yopN
sycN yscB tyeA) (−SycN/YscB) strains carrying pBAD18-YopN/TyeA or
one of the pBAD18-YopN/TyeA derivative encoding the YopN CBD
tetra-alanine mutants. Control strains included Y. pestis KIM8.P39 (parent)
and KIM8-3001.PF1 (sycN yscB). YopN present in the bacterial pellet (P)
and culture supernatant (S) fractions was detected by immunoblot analysis
with antiserum specific for YopN. The dashed lines indicate the margins of
individual blots shown in the merged images.
To further analyze the role of the YopN CBD in the regulation
of Yop secretion, a series of tetra-alanine substitution mutants
within the CBD were constructed. YopN CBD mutants cover-
ing residues 32–47, which mediate direct interactions with SycN,
were not required for the regulation of Yop secretion (Figure 3);
in contrast, tetra-alanine substitutions within residues 48–75,
the region that mediates interaction with YscB (Schubot et al.,
2005), were required for the regulation of Yop secretion. The
majority of these CBD tetra-alanine mutants maintained their
ability to bind the SycN/YscB chaperone as demonstrated via
immunoprecipitation assays. This suggests that the constitutive
secretion phenotype associated with these mutants could be due
to the disruption of CBD residues that have a direct function
in the regulation of Yop secretion, not to their interaction with
the SycN/YscB chaperone. This appears to be particularly true
for YopN residues V56–V59, which are part of an unstructured
region within the CBD that plays no role in the interaction of
YopN with the SycN/YscB chaperone, but does carry amino-acid
sequence-specific information required to regulate Yop secretion
(Schubot et al., 2005).
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To directly determine if the defect in the regulation of secre-
tion associated with specific YopN CBD tetra-alanine mutants
was due to a defect in SycN/YscB-dependent secretion or due to
a unique chaperone-independent function of the CBD, we evalu-
ated the ability of the seven YopNCBDmutants that secreted Yops
constitutively under normal (SycN/YscB chaperone-dependent)
conditions to regulate Yop secretion under the established
SycN/YscB-independent conditions (overexpression of YopN and
TyeA). Two of the mutants [YopN(S48-D51A) and YopN(F60-
R63A)] regained some ability to regulate Yop secretion under
the SycN/YscB-independent conditions, indicating that the ear-
lier defect in regulation was chaperone-dependent and likely the
result of an improper interaction between the mutant YopN
proteins and the SycN/YscB chaperone. Indeed, both SycN and
YscB failed to immunoprecipitate with the YopN(S48-D51A)
mutant. In contrast, both SycN and YscB immunoprecipi-
tated with YopN(F60-R63A), suggesting that the chaperone-
dependent defect in YopN function in this mutant was more
complex and not due to a simple loss of chaperone bind-
ing. Importantly, these types of mutations are expected and
support the previously identified role of the SycN/YscB chap-
erone in efficiently targeting YopN for secretion. In contrast,
to chaperone-dependent mutants discussed above, two of the
YopN CBD mutants [YopN(M52-E55A) and YopN(V56-V59A)]
secreted Yops constitutively under chaperone-independent con-
ditions, indicating that these mutants were likely defective in
regulation due to a unique (SycN/YscB-independent) role of the
YopN CBD in the regulation of Yop secretion.
What could be the direct role of the YopN CBD in the reg-
ulation of Yop secretion? Our current hypothesis proposes that
the N-terminal region of YopN (SS and CBD with the associated
SycN/YscB chaperone) is required for the efficient targeting of the
wild-type YopN/TyeA complex to the T3S apparatus. At the T3S
apparatus, the SycN/YscB chaperone may be removed, revealing
the CBD. Alternatively, it is possible that the SycN/YscB chaper-
one remains bound until the secretion of YopN is triggered. We
hypothesize that an early interactionmediated via the CBD region
is required for the C-terminal region of YopN complexed with
TyeA to establish its unique interaction with the T3S apparatus
that blocks Yop secretion. This CBD-dependent interaction with
the secretion apparatus may be required to induce a conforma-
tional change in the YopN/TyeA complex that is required for it
to establish its block in Yop secretion. This mechanism would
ensure that the YopN/SycN/YscB/TyeA complex would only block
the T3S process at the proper time, when the needle assem-
bly is complete and translocator- and effector-type substrates
are targeted to the T3S apparatus. We have previously isolated
mutations in YopN that allow the YopN/TyeA complex to con-
stitutively block secretion regardless of the level of extracellular
calcium (Ferracci et al., 2005). Surprisingly, these mutants no
longer required the YopN SS, CBD, or SycN/YscB chaperone to
block Yop secretion, confirming that the C-terminal region of
YopN complexed with TyeA mediates a unique interaction with
the T3S apparatus that blocks Yop secretion. We believe these
mutations result in a YopN/TyeA complex that is locked in a
blocking conformation and thus, no longer requires interactions
mediated via the YopN SS, CBD, and SycN/YscB chaperone to tar-
get the YopN/TyeA complex to the T3S apparatus and induce the
conformational change normally required to mediate a block in
Yop secretion. Confirmation of this model will require identifica-
tion of the T3SS components that YopN directly interacts with to
initiate the block in Yop secretion. A previous study found that
the Shigella flexneri MxiC protein, a homolog of YopN and TyeA,
interacts with Spa47, the (T3S) ATPase (YscN in the Yersinia
T3SS) (Botteaux et al., 2009). Similarly, the YscN ATPase likely
functions in the recognition of the YopN/SycN/YscB/TyeA com-
plex and ultimately to remove the SycN/YscB chaperone (Akeda
and Galan, 2005); thus, interactions with the T3SS ATPase could
simply represent a conserved step in the T3S secretion process and
may or may not play a unique role in the regulation of T3S secre-
tion process. Alternatively, structural analysis of the constitutive
blocking YopN mutants and comparisons with the structure of
wild-type YopNmay provide insight into conformational changes
required for YopN to block secretion.
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